Search - tctmd.com

Displaying 361 - 380 of 529

Sort: Relevancy | Date

Presentation THT Abstracts 2025

Evaluating the Impact of Sglt2 Inhibitors on Outcomes in Patients With Sarcoidosis and Heart Failure With Preserved Ejection Fraction

Presenter: Emmanuel Otabor

February 11, 2025

Presentation THT 2025

What Lessons Can We Learn from DanGer in the Management of HF-CS

Presenter: Jacob Abraham

February 11, 2025

Presentation THT 2025

What is the Long-Term Impact of Interatrial Shunting on Right Heart Function?

Presenter: JoAnn Lindenfeld

February 11, 2025

Presentation THT 2025

What Endpoints are Relevant for Evaluating how Interatrial Shunts Provide Clinical Benefit: Hemodynamic Exercise Testing and Beyond

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Residual Risk in HFpEF and the Potential Role of Interatrial Shunts

Presenter: Javed Butler

February 11, 2025

Presentation THT 2025

Real-world Results with Barostim within a Multi-disciplinary Heart Failure Program

Presenter: Patrick McCann

February 11, 2025

Presentation THT 2025

Patient Selection Protocols and Care Pathways within an Advanced Heart Failure Program

Presenter: Richa Gupta

February 11, 2025

Presentation THT 2025

Interatrial versus Coronary Sinus Shunting: Device and Procedural Comparisons

Presenter: Kamran Muhammad

February 11, 2025

Presentation THT 2025

Explain the Importance of Timely Identification of Patients in Heart Failure-Cardiogenic Shock (HF-CS)

Presenter: Navin Kapur

February 11, 2025

Presentation THT 2025

Drug and Device Therapies to Target the Neurohormonal Cascade

Presenter: Rajeev Mohan

February 11, 2025

Presentation THT 2025

Discuss Escalation Strategies for Patients in HF-CS

Presenter: Jane Wilcox

February 11, 2025

Presentation THT 2025

Position 2: It Should be Class I

Presenter: Navin Kapur

February 11, 2025

Presentation THT 2025

Position 1: It Should be Class IIa

Presenter: Manreet Kanwar

February 11, 2025

Presentation THT 2025

The Best Thing Since Sliced Bread.

Presenter: William Abraham

February 11, 2025

Presentation THT 2025

A Strategy That Has Created More Confusion Than Clarity.

Presenter: Milton Packer

February 11, 2025

Presentation THT 2025

Robotic Surgical Technique for Performing Heart Transplant

Presenter: Feras Khaliel

February 11, 2025

Presentation THT 2025

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Presenter: Javed Butler

February 11, 2025

Presentation THT 2025

Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis

Presenter: Gabriel Sayer

February 11, 2025

Presentation THT 2025

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) – The FASTR Trial

Presenter: James Udelson

February 11, 2025

Advertisement

Evaluating the Impact of Sglt2 Inhibitors on Outcomes in Patients With Sarcoidosis and Heart Failure With Preserved Ejection Fraction

What Lessons Can We Learn from DanGer in the Management of HF-CS

What is the Long-Term Impact of Interatrial Shunting on Right Heart Function?

What Endpoints are Relevant for Evaluating how Interatrial Shunts Provide Clinical Benefit: Hemodynamic Exercise Testing and Beyond

Residual Risk in HFpEF and the Potential Role of Interatrial Shunts

Real-world Results with Barostim within a Multi-disciplinary Heart Failure Program

Patient Selection Protocols and Care Pathways within an Advanced Heart Failure Program

Interatrial versus Coronary Sinus Shunting: Device and Procedural Comparisons

Explain the Importance of Timely Identification of Patients in Heart Failure-Cardiogenic Shock (HF-CS)

Drug and Device Therapies to Target the Neurohormonal Cascade

Discuss Escalation Strategies for Patients in HF-CS

Position 2: It Should be Class I

Position 1: It Should be Class IIa

The Best Thing Since Sliced Bread.

A Strategy That Has Created More Confusion Than Clarity.

Robotic Surgical Technique for Performing Heart Transplant

Left Atrial to Coronary Sinus Shunting in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The ALT FLOW Trial (Early Feasibility Study) 2-Year Results

Incidence and Outcome of Early and Late Right Ventricular Failure in Patients with the HeartMate 3 LVAD: A MOMENTUM 3 Analysis

Impact of Obesity Severity on the Effects of Tirzepatide in HFpEF: The SUMMIT Trial

Fluid Management of Acute Decompensated Heart Failure Subjects Treated With Reprieve Decongestion Management System (DMS) – The FASTR Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content